TrialNeuro-oncology2013

Phase II study of cilengitide in the treatment of refractory or relapsed high-grade gliomas in children: a report from the Children's Oncology Group.

Tobey J MacDonald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.